Victory Capital Management Inc. boosted its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 6.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 84,960 shares of the company's stock after buying an additional 4,913 shares during the quarter. Victory Capital Management Inc. owned approximately 0.47% of Addus HomeCare worth $11,302,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of ADUS. Ellsworth Advisors LLC bought a new position in Addus HomeCare during the 2nd quarter worth $598,000. Quadrature Capital Ltd acquired a new position in shares of Addus HomeCare during the 1st quarter worth $1,557,000. SG Americas Securities LLC bought a new position in Addus HomeCare in the second quarter valued at about $842,000. Dimensional Fund Advisors LP raised its stake in Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company's stock worth $82,930,000 after acquiring an additional 5,421 shares in the last quarter. Finally, Point72 Asset Management L.P. lifted its holdings in shares of Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock worth $86,598,000 after acquiring an additional 315,602 shares during the last quarter. Institutional investors own 95.35% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the stock. KeyCorp started coverage on shares of Addus HomeCare in a report on Friday, October 11th. They set an "overweight" rating and a $150.00 price target on the stock. Oppenheimer raised their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a report on Monday, September 23rd. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. Stephens upped their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a research note on Wednesday, November 6th. Finally, TD Cowen lifted their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a "buy" rating in a research report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $131.63.
Get Our Latest Research Report on ADUS
Insider Buying and Selling
In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. This represents a 12.93 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the business's stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares of the company's stock, valued at approximately $961,687.35. This represents a 75.23 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock valued at $3,050,082 over the last ninety days. 4.60% of the stock is owned by corporate insiders.
Addus HomeCare Price Performance
Shares of NASDAQ:ADUS opened at $120.99 on Thursday. Addus HomeCare Co. has a 1 year low of $85.43 and a 1 year high of $136.12. The business's 50-day moving average is $128.52 and its 200-day moving average is $122.88. The company has a market capitalization of $2.19 billion, a price-to-earnings ratio of 27.69, a P/E/G ratio of 2.09 and a beta of 1.04.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to analysts' expectations of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company's revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.03 EPS. Analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current year.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.